يعرض 1 - 20 نتائج من 43 نتيجة بحث عن '"Lam, Wei Sen"', وقت الاستعلام: 0.46s تنقيح النتائج
  1. 1
  2. 2
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
  6. 6
    Academic Journal
  7. 7
  8. 8
    Book

    المؤلفون: Lam, Wei-Sen, K. Nowak, Anna

    المصدر: Malignant Pleural Mesothelioma: Present Status and Future Directions ; page 305-320

  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal

    المصدر: The Lancet Oncology

    Relation: Nowak, Anna K., Lesterhuis, W. Joost, Kok, Peey Sei, Brown, Chris, Hughes, Brett GM, Karikios, Deme J., John, Thomas, Kao, Steven C-H., Leslie, Connull, Cook, Alistair M., Pavlakis, Nick, Briscoe, Karen, O'Byrne, Kenneth J., Karapetis, Christos S., Lam, Wei Sen, Langford, Ailsa, Yip, Sonia, & Stockler, Martin R. (2020) Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in. The Lancet Oncology, 21(9), pp. 1213-1223.; https://eprints.qut.edu.au/205013/; Centre for Genomics and Personalised Health; Institute of Health and Biomedical Innovation; Faculty of Health

  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal

    المصدر: Journal of Clinical Oncology

    Relation: Nowak, Anna K., Lesterhuis, Willem Joost, Hughes, Brett Gordon Maxwell, Brown, Chris, Kok, Peey Sei, O'Byrne, Kenneth John, John, Tom, Pavlakis, Nick, Kao, Steven Chuan-hao, Yip, Sonia, Karikios, Deme John, Lam, Wei-sen, Langford, Ailsa, & Stockler, Martin R. (2018) DREAM: A phase II study of durvalumab with first line chemotherapy in mesothelioma-First results. Journal of Clinical Oncology, 36(15_suppl), p. 8503.; https://eprints.qut.edu.au/233160/

  20. 20
    Academic Journal

    المصدر: Asia-Pacific Journal of Clinical Oncology

    Relation: Kok, Peey Sei, Stockler, Martin R., Lesterhuis, Willem J., Hughes, Brett, Brown, Chris, Kao, Steven C. H., Karikios, Deme J., John, Thomas, Pavlakis, Nick, O'Byrne, Ken, Yip, Sonia, Lam, Wei Sen, Briscoe, Karen, Karapetis, Christos Stelios, & Nowak, Anna K. (2018) DREAM - a phase 2 trial of DuRvalumab with first line chEmotherApy in mesothelioma: final result. Asia-Pacific Journal of Clinical Oncology, 14(S7), pp. 83-84.; https://eprints.qut.edu.au/233153/; Institute of Health and Biomedical Innovation